SCHEMBL7658616

SCHEMBL7658616

COCCN(C)C(=O)CC1C(=O)N(Cc2cncn2Cc2ccc(Br)cc2)C(=O)N1Cc1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FNTA P49354 9/20 0.46
FNTB P49356 9/20 0.46
PGGT1B P53609 4/20 0.46
HDAC6 Q9UBN7 4/20 0.44
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CNR2 P34972 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR2C P28335 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654002 0.85 HDAC6 (0.51) FNTAFNTBPGGT1BHDAC6CYP11B1
SCHEMBL7654667 0.78 CYP11B1 (0.51) FNTAFNTBPGGT1BHDAC6CYP11B1
SCHEMBL7653501 0.77 FNTA (0.48) FNTAFNTBPGGT1BHDAC6CYP11B1
SCHEMBL7656235 0.76 FNTA (0.48) FNTAFNTBPGGT1BHDAC6CYP11B1
SCHEMBL7656322 0.75 FNTA (0.44) FNTAFNTBPGGT1BHDAC6CYP11B1
SCHEMBL7656246 0.72 FNTA (0.48) FNTAFNTBPGGT1B
SCHEMBL6981780 0.72 FNTA (0.62) FNTAFNTBPGGT1BCYP11B1CYP11B2
SCHEMBL6983519 0.72 FNTA (0.76) FNTAFNTBPGGT1BCYP11B1CYP11B2
SCHEMBL7080004 0.70 FNTA (0.58) FNTAFNTBPGGT1BCYP11B1CYP11B2
SCHEMBL7654486 0.70 CYP11B1 (0.45) FNTAFNTBPGGT1BHDAC6CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US claimed
EP-1000036-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LIMITED (KR) 2000-05-17 EP claimed
WO-1999005117-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LTD. (KR) 1999-02-04 WO claimed
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US disclosed
EP-1000036-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LIMITED (KR) 2000-05-17 EP disclosed
WO-1999005117-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LTD. (KR) 1999-02-04 WO disclosed